Arnes JB, Brunet JS, Stefansson I, Bégin RL, Wong N, Chappuis PO, Akslen LA, Foulkes WD. (2005). Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer. Clin Cancer Res 11:4003-4011.
Baselga J, Arteaga CL. (2005). Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J Clin Oncol 23:2445-2459. [OpenAIRE]
Berquin IM, Dziubinski ML, Nolan GP, Ethier SP. (2001). A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin. Oncogene 20:4019-4028.
Berquin IM, Pang B, Dziubinski ML, Scott LM, Chen YQ, Nolan GP, Ethier SP. (2005). Y-box binding protein 1 confers EGFR independence to human mammary epithelial cells. Oncogene 24:3177-3186. [OpenAIRE]
Bhargava R, Gerald WL, Li AR, Pan Q, Lal P, Ladanyi M, Chen B. (2005). EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Modern Pathol 18:1027-1033.
Birnbaum D, Bertucci F, Ginestier C, Tagett R, Jacquemier J, Charafe-Jauffret E. (2004). Basal and luminal breast cancers: basic or luminous? Int J Oncol 25:249-258. [OpenAIRE]
Brunetti B, Sarli G, Preziosi R, Monari I, Benazzi C. (2005). E-cadherin and β-catenin reduction influence invasion but not proliferation in canine malignant mammary tumors. Vet Pathol 42:781-787. [OpenAIRE]
Chang SC, Chang CC, Chang TJ, Wong ML. (2005). Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumours: 79 cases (1998-2002). J Am Vet Med Ass 227:1625-1629.
Ciardiello F, Tortora G. (2003). Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs. Eur J Cancer 39:1348-1354. [OpenAIRE]
De las Mulas JM, Peña L. (2004). Comparison of canine mammary tumours routine histopathological diagnoses given by different groups of pathologists and applicability of the 1999 WHO's classification. Proceedings of 12th Annual Meeting of the Portuguese Society of Animal Pathology jointly with 16th Annual Meeting of the Spanish Society of Veterinary Pathology, pp. 46-47.
De Matos AJ, Lopes CC, Faustino AM, Carvalheira JG, Dos Santos MS, Rutteman GR, Gärtner MF. (2006). MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study. Anticancer Res 26:1821-1826. [OpenAIRE]